TELO
Telomir Pharmaceuticals, Inc. Common Stock
NASDAQ · Healthcare · Biotechnology · US
$1.16
+0.00%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-116.7%
Return on equity
-109.5%
Return on assets
-120.9%
Return on invested capital
0.00x
Asset turnover
-$4.9M
Cash from operations
$0.08
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026